The multi-mechanism effects of traditional Chinese medicine in rheumatoid arthritis treatment: Analysis of signaling pathways and prospects
Letters in Drug Design & Discovery · 2026-11 · 100649
DOI: 10.1016/j.lddd.2026.100649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-11. Verfasst von Hao Zhang und 8 weiteren Autor:innen. Die Arbeit nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent synovial inflammation, cartilage degradation, and bone erosion. Traditional Chinese medicine (TCM) is widely used as an adjunctive therapy for RA, but its mechanisms and clinical value remain incompletely defined. This narrative review summarizes the therapeutic effects, molecular mechanisms, and potential clinical applications of TCM, with emphasis on signaling pathways, multi-omics, combination therapy, and digital health.
Methods
PubMed, Web of Science, China National Knowledge Infrastructure, and ScienceDirect were searched for English and Chinese-language publications from January 2010 to July 2024. Search terms combined “rheumatoid arthritis” with “traditional Chinese medicine,” “Chinese herbal medicine,” “herbal formula,” “bioactive compounds,” “signaling pathways,” “multi-omics,” “combination therapy,” and “digital health.” Relevant preclinical and clinical studies were synthesized narratively, with selected reviews used for background and reference tracing. No formal risk-of-bias assessment or meta-analysis was performed.
Results
Evidence suggests that TCM may exert anti-inflammatory, immunomodulatory, antioxidant, and bone-protective effects through NF-κB, MAPK, JAK/STAT, PI3K/AKT, Wnt/β-catenin, and Nrf2/HO-1 signaling. Reported effects include reduced production of TNF-α, IL-1β, IL-6, and IL-17 and inhibition of RANKL-mediated osteoclastogenesis. Transcriptomic, metabolomic, proteomic, and microbiome studies have identified potential TCM-responsive biomarkers and interactions among immune, metabolic, oxidative-stress, and gut microbiota-related pathways. Preliminary clinical evidence suggests that combining TCM with conventional antirheumatic therapy, particularly methotrexate, may improve clinical responses and reduce treatment-related adverse effects. Digital health may support symptom monitoring, individualized treatment, and long-term management. However, most mechanistic evidence derives from cell and animal studies, many network-pharmacology targets remain computational predictions, and clinical evidence is limited and heterogeneous.
Conclusion
TCM may attenuate synovial inflammation and joint destruction through coordinated regulation of immune, inflammatory, oxidative, metabolic, and bone-remodeling processes. Nevertheless, confidence in individual mechanisms depends on study design and experimental validation. Predicted targets should remain hypothesis-generating until confirmed by causal cellular experiments, in vivo studies, and clinical investigation.
Zitieren
APA
Zhang, H., Ren, C., Li, H., Cheng, W., Jin, F., Kan, L., Yang, H., Chen, P., & Wang, H. (2026). The multi-mechanism effects of traditional Chinese medicine in rheumatoid arthritis treatment: Analysis of signaling pathways and prospects. Letters in Drug Design & Discovery, 100649. https://doi.org/10.1016/j.lddd.2026.100649
Vancouver
Zhang H, Ren C, Li H, Cheng W, Jin F, Kan L, et al. The multi-mechanism effects of traditional Chinese medicine in rheumatoid arthritis treatment: Analysis of signaling pathways and prospects. Letters in Drug Design & Discovery. 2026:100649. doi:10.1016/j.lddd.2026.100649
BibTeX
@article{Zhang2026,
author = {Zhang, Hao and Ren, Chunzhen and Li, Haolin and Cheng, Weigang and Jin, Fangmei and Kan, Lili and Yang, Huijun and Chen, Ping and Wang, Haidong},
title = {The multi-mechanism effects of traditional Chinese medicine in rheumatoid arthritis treatment: Analysis of signaling pathways and prospects},
journal = {Letters in Drug Design & Discovery},
year = {2026},
pages = {100649},
doi = {10.1016/j.lddd.2026.100649}
}
EUVIMED